In the original article, old type of electrodes were incorrectly identified as (NM-990W) instead of (NM-983W). In addition, the average of P-IES in non-diabetic/IFG subjects was incorrect. The correct value is "0.15 ± 0.01."

A correction has been made in the following places:

The Material and Methods section, subsection P-IES Measurement, paragraph 1:

"For nociceptive stimulation, an IES method was adopted using a disposable concentric bipolar needle electrode (NM-983W; Nihon Kohden Corp., Tokyo, Japan) which was connected to a specific stimulator for cutaneous Aδ and C fibers as previously described (PNS-7000; Nihon Kohden) (15)."

The Abstract, subsection Results:

"P-IES was elevated with increasing of age in women but not in men. Average P-IES (mA) was increased in IFG subjects (*n* = 55, 0.20 ± 0.03) compared with normoglycemic/non-IFG individuals (*n* = 894, 0.15 ± 0.01) (*p* \< 0.01). It was comparable between IFG and a group of normal high HbA1c (5.9--6.4%). Univariate linear regression analyses showed no influence of sex, triglyceride, or cholesterol on the value of P-IES. In contrast, there were significant correlations between P-IES and serum HbA1c level (ß = 0.120, *p* \< 0.001) Adjustments for the multiple clinical measurements confirmed positive correlation of P-IES with HbA1c (ß = 0.077, *p* = 0.046)."

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
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